Stockscreener 앱 받기
8.27
0.72%
-0.06
시간 외 거래:
8.25
-0.02
-0.24%
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Cathie Wood’s Ark Invest Makes Bold Moves: Buys BEAM & NU, Sells MELI & ADPT - Apna Kal
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies - Benzinga India
Adaptive Biotechnologies CEO Chad Robins sells over $2.4m in stock - Investing.com Nigeria
Cathie Wood's ARK buys Beam Therapeutics, sells Adaptive Biotech stock By Investing.com - Investing.com Australia
Cathie Wood's ARK buys Beam Therapeutics, sells Adaptive Biotech stock - Investing.com India
Adaptive Biotechnologies CEO Chad Robins sells $3.99 million in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $3.99 million in shares - Investing.com
Adaptive Biotechnologies CEO Chad M Robins Sells Over $3.9 Million in Company Stock - TradingView
ADPT stock soars to 52-week high, reaching $8.33 - MSN
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 7.9% Following Analyst Upgrade - Armenian Reporter
Scotiabank Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) Stock - Defense World
Legato Capital Management LLC Decreases Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 7.9% on Analyst Upgrade - MarketBeat
Scotiabank Issues Positive Forecast for Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price - MarketBeat
Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank - Yahoo Finance
Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements - MSN
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates - MSN
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Down 5.2%Time to Sell? - MarketBeat
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2024 Earnings Call Transcript - Insider Monkey
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ... By GuruFocus - Investing.com Canada
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highl - GuruFocus.com
Adaptive Biotechnologies: Q4 Earnings Snapshot - The Advocate
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance
Adaptive Biotechnologies Q4 revenue beats estimates, loss narrower than expected - Investing.com
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings: EPS of -$ - GuruFocus.com
Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Adaptive Biotechnologies earnings beat by $0.02, revenue topped estimates - Investing.com
Adaptive Biotechnologies' Q4 Loss Narrows, Revenue Rises -February 11, 2025 at 05:12 pm EST - Marketscreener.com
Adaptive Biotechnologies: Q4 Earnings Snapshot -February 11, 2025 at 04:46 pm EST - Marketscreener.com
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Earnings Flash (ADPT) Adaptive Biotechnologies Reports Q4 Revenue $47.5M, vs. FactSet Est of $46.0M - Marketscreener.com
Adaptive's MRD Division Hits Record Growth: Medicare Boosts Test Rates 17% as Volume Soars - StockTitan
Earnings Scheduled For February 11, 2025 - Benzinga
Gaining Ground: Adaptive Biotechnologies Corp (ADPT) Closes Lower at 7.84, Down -2.12 - The Dwinnex
Adaptive Biotechnologies (ADPT) to Release Earnings on Tuesday - Defense World
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Pre - GuruFocus.com
Gaining Ground: Hepion Pharmaceuticals Inc (HEPA) Closes Higher at 0.17, Up 3.43 - The Dwinnex
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 9.8%What's Next? - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Down 4.6%Should You Sell? - MarketBeat
It makes sense and dollars to buy Adaptive Biotechnologies Corp (ADPT) stock - SETE News
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - Yahoo Finance
Analysts review Adaptive Biotechnologies Corp’s rating - Knox Daily
Adaptive Biotechnologies Corp (ADPT) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Sumitomo Mitsui Trust Group, Inc. Reduces Stake in Adaptive Biot - GuruFocus.com
Stock Performance Spotlight: Adaptive Biotechnologies Corp (ADPT) Ends the Day at 7.70, Down by -0.65 - The Dwinnex
How did Adaptive Biotechnologies Corp (ADPT) fare last session? - US Post News
Adaptive Biotechnologies (ADPT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
The Goldman Sachs Group Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat
The Goldman Sachs Group Increases Adaptive Biotechnologies (NASDAQ:ADPT) Price Target to $7.50 - Defense World
The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99% - Yahoo Finance
0.27%
3.05%
자본화:
|
볼륨(24시간):